{"entity":{"type":"insider","cik":"0001718019","url":"/insider/0001718019","json_url":"/insider/0001718019.json","name":"Notman Donald","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":10,"first":"2017-12-08","last":"2026-02-17","span_basis":"filed_date"},"name_variants":[{"name":"Notman Donald","source":"filing","n_filings":10,"first_seen":"2017-12-08","last_seen":"2026-02-17"}],"transactions":[{"id":6226199,"accession":"0001104659-26-016668","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-016668","line_url":"/filing/0001104659-26-016668#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11446.0,"shares_display":"11,446","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":103471.84,"total_display":"103,471.84","total_whole":"103,472","shares_owned_after":366356.0,"shares_owned_after_display":"366,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":5833291,"accession":"0001104659-26-010462","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-26-010462","line_url":"/filing/0001104659-26-010462#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6035.0,"shares_display":"6,035","price_per_share":8.54,"price_display":"8.54","price_state":"stated","total_value":51538.9,"total_display":"51,538.90","total_whole":"51,539","shares_owned_after":377802.0,"shares_owned_after_display":"377,802","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-04","scope":"insider"},{"id":5833289,"accession":"0001104659-26-010462","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-010462","line_url":"/filing/0001104659-26-010462#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5455.0,"shares_display":"5,455","price_per_share":9.14,"price_display":"9.14","price_state":"stated","total_value":49858.7,"total_display":"49,858.70","total_whole":"49,859","shares_owned_after":383837.0,"shares_owned_after_display":"383,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5207134,"accession":"0001104659-25-087498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-087498","line_url":"/filing/0001104659-25-087498#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1066.0,"shares_display":"1,066","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":13250.38,"total_display":"13,250.38","total_whole":"13,250","shares_owned_after":308807.0,"shares_owned_after_display":"308,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-02","filed_date":"2025-09-04","scope":"insider"},{"id":5128287,"accession":"0001104659-25-009254","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-009254","line_url":"/filing/0001104659-25-009254#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11119.0,"shares_display":"11,119","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":86839.39,"total_display":"86,839.39","total_whole":"86,839","shares_owned_after":193444.0,"shares_owned_after_display":"193,444","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":5128280,"accession":"0001104659-25-009254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-009254","line_url":"/filing/0001104659-25-009254#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6301.0,"shares_display":"6,301","price_per_share":7.84,"price_display":"7.84","price_state":"stated","total_value":49399.84,"total_display":"49,399.84","total_whole":"49,400","shares_owned_after":204563.0,"shares_owned_after_display":"204,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-31","filed_date":"2025-02-04","scope":"insider"},{"id":2528949,"accession":"0001104659-24-011196","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-011196","line_url":"/filing/0001104659-24-011196#line-2","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6212.0,"shares_display":"6,212","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":30190.32,"total_display":"30,190.32","total_whole":"30,190","shares_owned_after":195356.0,"shares_owned_after_display":"195,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":3153786,"accession":"0001104659-24-010238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-010238","line_url":"/filing/0001104659-24-010238#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6433.0,"shares_display":"6,433","price_per_share":4.95,"price_display":"4.95","price_state":"stated","total_value":31843.35,"total_display":"31,843.35","total_whole":"31,843","shares_owned_after":139932.0,"shares_owned_after_display":"139,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-02","scope":"insider"},{"id":8072484,"accession":"0001104659-23-014684","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-014684","line_url":"/filing/0001104659-23-014684#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6476.0,"shares_display":"6,476","price_per_share":4.24,"price_display":"4.24","price_state":"stated","total_value":27458.24,"total_display":"27,458.24","total_whole":"27,458","shares_owned_after":139387.0,"shares_owned_after_display":"139,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-06","filed_date":"2023-02-08","scope":"insider"},{"id":8237510,"accession":"0001104659-19-036009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-036009","line_url":"/filing/0001104659-19-036009#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":4.33,"price_display":"4.33","price_state":"stated","total_value":10825.0,"total_display":"10,825.00","total_whole":"10,825","shares_owned_after":24049.0,"shares_owned_after_display":"24,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-17","scope":"insider"},{"id":6221159,"accession":"0001104659-18-052308","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-052308","line_url":"/filing/0001104659-18-052308#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":78625.0,"total_display":"78,625.00","total_whole":"78,625","shares_owned_after":17300.0,"shares_owned_after_display":"17,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-15","scope":"insider"},{"id":4656809,"accession":"0001104659-17-072536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-072536","line_url":"/filing/0001104659-17-072536#line-1","is_derivative":false,"issuer_cik":"0001393434","issuer_name":"OCULAR THERAPEUTIX, INC","issuer_ticker":"OCUL","issuer_name_source":null,"issuer_url":"/issuer/0001393434","owner_cik":"0001718019","owner_name":"Notman Donald","owner_display_name":"Notman Donald","owner_url":"/insider/0001718019","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4800.0,"shares_display":"4,800","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":19200.0,"total_display":"19,200.00","total_whole":"19,200","shares_owned_after":4800.0,"shares_owned_after_display":"4,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-07","filed_date":"2017-12-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001393434","name":"OCULAR THERAPEUTIX, INC","url":"/issuer/0001393434","role":"Officer (Chief Operating Officer)","n_filings":10,"first_seen":"2017-12-08","last_seen":"2026-02-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001718019","retrieved_at":"2026-08-24T22:52:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}